Skip to main content

The latest news &
insights from ArteraAI

View company news, research articles, publications, and industry thought leadership currently making headlines in the cancer treatment space.

Show All
Resources
Upcoming & Past Events
Press & Media
Publications & Presentations
Videos
Insights
Press & Media

U.S. FDA Grants Artera Breakthrough Device Designation for AI-Powered...

Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, announced to [...]

Press & Media

Multimodal AI Shows No Evidence of Bias in Prostate...

The study evaluated the performance of a multimodal artificial intelligence model to close gaps in care and validate that AI [...]

Press & Media

Artera Bullish on Prostate Cancer Test Following NYS Approval,...

NEW YORK – Startup firm Artera is continuing to make commercial progress with its artificial intelligence-based prostate canc [...]

Press & Media

AI News: Artera presented data at #ASCO25 showing that...

CMO Tim Showalter describes the finding, which was selected as a "Best of ASCO" oral presentation. Plus, helping to determine [...]

Press & Media

Artera Launches Registry Trial to Measure Real-World Impact and...

Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, announced th [...]

Insights

Artera Product Webinar – June 2025

The ArteraAI Prostate Test is transforming the risk stratification landscape for treating localized prostate cancer. Watch th [...]

Press & Media

How AI Is Helping Cancer Patients: Saving Lives And...

Cancer treatment is costly. The average cost of cancer care in the U.S. is around $150,000 per patient—more than four times t [...]

Videos

Multimodal AI Test Predicts Prostate Cancer Metastasis and Treatment...

Leslie Ballas speaks with Timothy Showalter about a multimodal artificial intelligence-based prostate cancer test. Dr. Showal [...]

Load More